Squarepoint Ops LLC Nektar Therapeutics Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.49 - $0.96 $43,798 - $85,809	-89,385 Reduced 69.74%	38,781 $36,000
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.57 $288,385 - $391,380	-686,633 Reduced 84.27%	128,166 $71,000
Q2 2023 Aug 14, 2023	BUY	$0.53 - $1.03 $71,171 - $138,313	134,285 Added 19.73%	814,799 $472,000
Q1 2023 May 15, 2023	BUY	$0.64 - $3.15 $405,912 - $2 Million	634,238 Added 1370.55%	680,514 $476,000
Q4 2022 Feb 14, 2023	SELL	$2.03 - $4.28 $175,467 - $369,950	-86,437 Reduced 65.13%	46,276 $104,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $403,447 - $682,144	132,713 New	132,713 $425,000
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $457,196 - $889,874	-144,226 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.16 - $13.72 $68,236 - $225,049	-16,403 Reduced 10.21%	144,226 $777,000
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $1.61 Million - $2.74 Million	148,754 Added 1252.67%	160,629 $2.17 Million
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $1 Million - $1.44 Million	-76,626 Reduced 86.58%	11,875 $213,000
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $1.14 Million - $1.4 Million	68,806 Added 349.36%	88,501 $1.52 Million
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $203,936 - $313,539	-12,315 Reduced 38.47%	19,695 $394,000
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $436,671 - $526,940	-27,690 Reduced 46.38%	32,010 $544,000
Q3 2020 Nov 16, 2020	BUY	$16.59 - $24.79 $990,423 - $1.48 Million	59,700 New	59,700 $990,000
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $1.3 Million - $1.81 Million	-77,334 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $650,412 - $1.26 Million	-44,949 Reduced 36.76%	77,334 $1.38 Million
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $1.46 Million - $2.13 Million	-92,016 Reduced 42.94%	122,283 $2.64 Million
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $3.62 Million - $7.77 Million	214,299 New	214,299 $3.9 Million
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $4.69 Million - $6.88 Million	-148,478 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $2.61 Million - $4.86 Million	-85,789 Reduced 36.62%	148,478 $4.88 Million
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $8.21 Million - $12.1 Million	176,619 Added 306.37%	234,267 $14.3 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $2.67 Million - $6.02 Million	57,648 New	57,648 $2.82 Million

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$14.8 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$14.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$12.2 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$8.74 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$8.56 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account